Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News NovaBay Pharmaceuticals Inc New NBY

Healthcare Biotechnology
NovaBay Pharmaceuticals, Inc. manufactures and sells wound care products. The company offers hypochlorous acid for use in the cleansing and irrigation of post-surgical wounds, minor burns, and superficial abrasions. It sells its products to its distribution partners in China. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in... see more

Current News (NYSEAM:NBY)

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards

GlobeNewswire October 20, 2025

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

Business Wire March 7, 2025

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

Business Wire January 23, 2025

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

Business Wire December 19, 2024

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

Business Wire December 9, 2024

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

Business Wire November 22, 2024

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand

Business Wire November 15, 2024

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

Business Wire November 7, 2024

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

Business Wire November 6, 2024
View More News ››

Opinion & Analysis (NYSEAM:NBY)

A clear vision for a turnaround: Ron Najafi of NovaBay Pharmaceuticals

George S. Mack June 25, 2015
View More Opinion ››

Bullboard Posts (NYSEAM:NBY)

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - August 27, 2025

NovaBay Pharmaceuticals, Inc. (NBY): Laser-Focused on the Lu

http://beyondspx.com/2024/08/01/novabay-pharmaceuticals-inc-nby-laser-focused-on-the-lucrative-dry-eye-market/
MikeTester - August 1, 2024

Real stock price share value

5.25$
Nibinator - November 15, 2023

I m very conservative on that 150%

Looking for 300%
Nibinator - October 28, 2023

Who wants to make 150 % in 2 weeks

Me
Nibinator - October 28, 2023

15 november that will hit

0.85 easy
Nibinator - October 28, 2023
View more Bullboard ››

Vesalius Longevity Labs

Vesalius Longevity Labs

View More »

Podcasts